Company profile for Altavant Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Altavant Sciences is a clinical stage biopharmaceutical company formed to advance promising therapies that treat rare respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). Our goal is to develop life-saving medicines for patients with rare respiratory diseases. At Altavant, we are driven by several objectives: Develop rodatristat ethyl*, our lead TPH inhibitor candidate for the treatm...
Altavant Sciences is a clinical stage biopharmaceutical company formed to advance promising therapies that treat rare respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). Our goal is to develop life-saving medicines for patients with rare respiratory diseases. At Altavant, we are driven by several objectives: Develop rodatristat ethyl*, our lead TPH inhibitor candidate for the treatment of patients with pulmonary arterial hypertension (PAH).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6501 Weston Parkway, Suite 330 Cary, NC 27513
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/sumitovant-subsidiaries-enzyvant-and-altavant-merge-into-combined-company/

Tyler Patchen ENDPTS
06 Dec 2022

https://www.prnewswire.com/news-releases/altavant-sciences-presents-data-showing-potential-for-combination-of-rodatristat-ethyl-and-ambrisentan-in-model-of-pulmonary-arterial-hypertension-301541434.html

PRNEWSWIRE
06 May 2022

https://www.prnewswire.com/news-releases/altavant-sciences-presented-data-at-ishlt-showing-potency-and-distribution-of-bronchiolitis-obliterans-candidate-alta-2530-301536741.html

PRNEWSWIRE
02 May 2022

https://www.prnewswire.com/news-releases/altavant-sciences-to-present-data-at-ishlt-showing-potency-and-distribution-of-bronchiolitis-obliterans-candidate-alta-2530-301532140.html

PRNEWSWIRE
25 Apr 2022

https://www.prnewswire.com/news-releases/altavant-sciences-highlights-ongoing-phase-2b-elevate-2-study-of-rodatristat-ethyl-in-patients-with-pulmonary-arterial-hypertension-at-european-respiratory-society-annual-congress-301375357.html

PRNEWSWIRE
13 Sep 2021

https://www.biospace.com/article/releases/altavant-sciences-reports-rodatristat-ethyl-pk-pd-analysis-at-ats-supporting-doses-selected-for-phase-2b-elevate-2-study/

BIOSPACE
20 May 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty